Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Oropharyngeal Neoplasms 1Non-Small Cell Lung Cancer NSCLC 1Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Liver Diseases 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 60Vincristine 57Doxorubicin 54Rituximab 48Prednisone 44Etoposide 35Radiotherapy 34Cytarabine 26Filgrastim 22Methotrexate 21Bleomycin 21Dexamethasone 18Peripheral Blood Stem Cell Transplantation 14Carmustine 14Vinblastine 13Prednisolone 13VAP-cyclo protocol 12Melphalan 12Mitoxantrone 11Mercaptopurine 10Leucovorin 10Dacarbazine 9Ifosfamide 8Granulocyte Colony-Stimulating Factor 8Procarbazine 7Methylprednisolone 7Lenalidomide 7Gemcitabine 7Daunorubicin 7Cisplatin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma × Fluorodeoxyglucose F18 × Clear all
NCT00433459 2020-03-26

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Martin-Luther-Universität Halle-Wittenberg

Phase 3 Completed
2,134 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡